These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9392337)

  • 1. Pleomorphic xanthoastrocytoma: DNA flow cytometry and outcome analysis of 12 patients.
    Rostomily RC; Hoyt JW; Berger MS; Kros JM; Alvord EC; Wilkins P; Rabinovitch P
    Cancer; 1997 Dec; 80(11):2141-50. PubMed ID: 9392337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleomorphic xanthoastrocytoma: what do we really know about it?
    Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
    Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic xanthoastrocytoma in children and adolescents.
    Rao AA; Laack NN; Giannini C; Wetmore C
    Pediatr Blood Cancer; 2010 Aug; 55(2):290-4. PubMed ID: 20582976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic alterations in pleomorphic xanthoastrocytoma.
    Paulus W; Lisle DK; Tonn JC; Wolf HK; Roggendorf W; Reeves SA; Louis DN
    Acta Neuropathol; 1996; 91(3):293-7. PubMed ID: 8834542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.
    Asano K; Miyamoto S; Kubo O; Kikkukawa T; Yagihashi A; Ohkuma H
    Brain Tumor Pathol; 2006 Apr; 23(1):55-63. PubMed ID: 18095120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar pleomorphic xanthoastrocytoma: case report and literature review.
    Hamlat A; Le Strat A; Guegan Y; Ben-Hassel M; Saikali S
    Surg Neurol; 2007 Jul; 68(1):89-94; discussion 94-5. PubMed ID: 17537486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleomorphic xanthoastrocytoma].
    Vajtai I; Varga Z
    Orv Hetil; 1997 Apr; 138(16):991-7. PubMed ID: 9190551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
    Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
    Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro.
    Spaar FW; Ahyai A; Spaar U; Gazsó L; Zimmermann A
    Clin Neuropathol; 1986; 5(4):157-75. PubMed ID: 3757347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis.
    Granger JK; Houn HY
    South Med J; 1990 Dec; 83(12):1407-12. PubMed ID: 2251529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types.
    Hirose T; Ishizawa K; Sugiyama K; Kageji T; Ueki K; Kannuki S
    Histopathology; 2008 Jan; 52(2):183-93. PubMed ID: 18184267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis.
    Pahapill PA; Ramsay DA; Del Maestro RF
    Neurosurgery; 1996 Apr; 38(4):822-8; discussion 828-9. PubMed ID: 8692406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.
    Shepherd CW; Scheithauer BW; Gomez MR; Altermatt HJ; Katzmann JA
    Neurosurgery; 1991 Jun; 28(6):864-8. PubMed ID: 2067610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.
    Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T
    World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological features of gliomas in children.
    Hirato J; Nakazato Y
    Noshuyo Byori; 1996 Apr; 13(1):37-47. PubMed ID: 8916125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of pleomorphic xanthoastrocytoma.
    Nakajima T; Kumabe T; Shamoto H; Watanabe M; Suzuki H; Tominaga T
    Acta Neurochir (Wien); 2006 Jan; 148(1):67-71; discussion 71. PubMed ID: 15912255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.